Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Prolyl endopeptidase activity is correlated with colorectal cancer prognosis.

Larrinaga G, Perez I, Blanco L, Sanz B, Errarte P, Beitia M, Etxezarraga MC, Loizate A, Gil J, Irazusta J, López JI.

Int J Med Sci. 2014 Jan 10;11(2):199-208. doi: 10.7150/ijms.7178. eCollection 2014.

2.

Dipeptidyl-peptidase IV activity is correlated with colorectal cancer prognosis.

Larrinaga G, Perez I, Sanz B, Beitia M, Errarte P, Fernández A, Blanco L, Etxezarraga MC, Gil J, López JI.

PLoS One. 2015 Mar 19;10(3):e0119436. doi: 10.1371/journal.pone.0119436. eCollection 2015.

3.

Aminopeptidase N activity predicts 5-year survival in colorectal cancer patients.

Sanz B, Perez I, Beitia M, Errarte P, Fernández A, Blanco L, Estalella I, Loizate A, Irazusta J, López JI, Larrinaga G.

J Investig Med. 2015 Jun;63(5):740-6. doi: 10.1097/JIM.0000000000000199.

PMID:
25929234
4.

Clinical impact of aspartyl aminopeptidase expression and activity in colorectal cancer.

Larrinaga G, Perez I, Ariz U, Sanz B, Beitia M, Errarte P, Etxezarraga C, Candenas ML, Pinto FM, López JI.

Transl Res. 2013 Nov;162(5):297-308. doi: 10.1016/j.trsl.2013.07.010. Epub 2013 Aug 13.

PMID:
23948443
5.

The role of cysteine and serine proteases in colorectal carcinoma.

Herszènyi L, Plebani M, Carraro P, De Paoli M, Roveroni G, Cardin R, Tulassay Z, Naccarato R, Farinati F.

Cancer. 1999 Oct 1;86(7):1135-42.

PMID:
10506696
6.

Expression of ZNF148 in different developing stages of colorectal cancer and its prognostic value: a large Chinese study based on tissue microarray.

Gao XH, Liu QZ, Chang W, Xu XD, Du Y, Han Y, Liu Y, Yu ZQ, Zuo ZG, Xing JJ, Cao G, Fu CG.

Cancer. 2013 Jun 15;119(12):2212-22. doi: 10.1002/cncr.28052. Epub 2013 Apr 10.

7.

Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.

Shi H, Zhou Y, Liu H, Chen C, Li S, Li N, Li X, Zhang X, Zhang H, Wang W, Zhao Q.

BMC Cancer. 2010 Sep 3;10:477. doi: 10.1186/1471-2407-10-477.

8.

MTSS1 overexpression correlates with poor prognosis in colorectal cancer.

Wang D, Xu MR, Wang T, Li T, Zhu Jw.

J Gastrointest Surg. 2011 Jul;15(7):1205-12. doi: 10.1007/s11605-011-1546-2. Epub 2011 May 12.

PMID:
21562916
9.
10.

Increased prolyl endopeptidase activity in human neoplasia.

Larrinaga G, Perez I, Blanco L, López JI, Andrés L, Etxezarraga C, Santaolalla F, Zabala A, Varona A, Irazusta J.

Regul Pept. 2010 Aug 9;163(1-3):102-6. doi: 10.1016/j.regpep.2010.03.012. Epub 2010 Apr 1.

PMID:
20362629
11.

Components of biological variation in prolyl endopeptidase and dipeptidyl-peptidase IV activity in plasma of healthy subjects.

Maes M, Scharpé S, De Meester I, Goossens P, Wauters A, Neels H, Verkerk R, De Meyer F, D'Hondt P, Peeters D, et al.

Clin Chem. 1994 Sep;40(9):1686-91.

12.

CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.

Kawamura M, Toiyama Y, Tanaka K, Saigusa S, Okugawa Y, Hiro J, Uchida K, Mohri Y, Inoue Y, Kusunoki M.

Eur J Cancer. 2012 Sep;48(14):2244-51. doi: 10.1016/j.ejca.2011.11.032. Epub 2011 Dec 24.

PMID:
22197219
13.

Altered Activity and Expression of Cytosolic Peptidases in Colorectal Cancer.

Perez I, Blanco L, Sanz B, Errarte P, Ariz U, Beitia M, Fernández A, Loizate A, Candenas ML, Pinto FM, Gil J, López JI, Larrinaga G.

Int J Med Sci. 2015 Jun 2;12(6):458-67. doi: 10.7150/ijms.11808. eCollection 2015.

14.

Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.

Hu WG, Li JW, Feng B, Beveridge M, Yue F, Lu AG, Ma JJ, Wang ML, Guo Y, Jin XL, Zheng MH.

Eur Surg Res. 2007;39(4):229-38. Epub 2007 Apr 19.

PMID:
17446709
15.

Prognostic implications of serum microRNA-21 in colorectal cancer.

Menéndez P, Padilla D, Villarejo P, Palomino T, Nieto P, Menéndez JM, Rodríguez-Montes JA.

J Surg Oncol. 2013 Nov;108(6):369-73. doi: 10.1002/jso.23415. Epub 2013 Aug 23.

PMID:
23970420
16.

Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.

Gaber A, Nodin B, Hotakainen K, Nilsson E, Stenman UH, Bjartell A, Birgisson H, Jirström K.

BMC Cancer. 2010 Sep 17;10:498. doi: 10.1186/1471-2407-10-498.

17.

Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.

Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K.

Ann Surg Oncol. 2012 Oct;19(11):3422-31. doi: 10.1245/s10434-012-2384-5. Epub 2012 May 11.

PMID:
22576063
18.

Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer.

Yang XQ, Li Y, Chen C, Peng CW, Liu SP, Liu Y.

Med Oncol. 2011 Sep;28(3):789-95. doi: 10.1007/s12032-010-9518-z. Epub 2010 Apr 7.

PMID:
20373053
19.

Circulating levels of periostin may help identify patients with more aggressive colorectal cancer.

Ben QW, Zhao Z, Ge SF, Zhou J, Yuan F, Yuan YZ.

Int J Oncol. 2009 Mar;34(3):821-8.

PMID:
19212687
20.

Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.

Tachezy M, Zander H, Gebauer F, Marx A, Kaifi JT, Izbicki JR, Bockhorn M.

J Surg Res. 2012 Sep;177(1):e15-20. doi: 10.1016/j.jss.2012.02.013. Epub 2012 Mar 30.

PMID:
22482754

Supplemental Content

Support Center